Medicine policy

Analysis of AMMPS's 2025-2028 digital roadmap, covering integrated systems, medicine traceability, transparency, regulatory performance and pharmaceutical sovereignty.

Analysis of Morocco’s morphine alert and what it reveals about vital medicine supply, from imports and logistics to local production, generics and pharmaceutical governance.

Analysis of Morocco's medicine pricing reform, from price reductions and AMO reimbursement control to generics, local production and sector resistance.

Morocco's Competition Council is examining medicine distribution, with issues linked to prices, margins, generics, quality and competitive practices.

Biosimilars are emerging as a lever to reduce treatment costs in Morocco, improve access to care and strengthen local pharmaceutical production.

A draft decree would more strictly regulate medicine advertising in Morocco, with prior approval, transparency requirements and public consultation.